Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 antiparkinsonism agent trial in Japan (jRCT2080223219)
jRCT2080223219Phase 2Terminated
- Start
- May 2016
01
Overview
Phase 2 trial in Parkinson's disease (PD). Started May 2016; status: terminated.
02
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2080223219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223219.